Acceder Registro /

FRANCISCO JUAN MARTINEZ NAVARRO

Buscador

Martínez-Morcillo FJ, Cantón-Sandoval J, Martínez-Navarro FJ, Cabas I, Martínez-Vicente I, Armistead J, Hatzold J, López-Muñoz A, Martínez-Menchón T, Corbalán-Vélez R, Lacal J, Hammerschmidt M, García-Borrón JC, García-Ayala A, Cayuela ML, Pérez-Oliva AB, García-Moreno D, Mulero V. NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death. PLoS Biol. 2021 Nov 8;19(11):e3001455. doi: 10.1371/journal.pbio.3001455. eCollection 2021 Nov. PubMed PMID: 34748530; PubMed Central PMCID: PMC8601609.
AÑO: 2021; IF: 9.593
Autores:
Hernandez-Silva D, Canton-Sandoval J, Martinez-Navarro FJ, Perez-Sanchez H, de Oliveira S, Mulero V, Alcaraz-Perez F, Cayuela ML. Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic Inflammation. Int J Mol Sci. 2022 Sep 9;23(18):10468. doi: 10.3390/ijms231810468. PubMed PMID: 36142384; PubMed Central PMCID: PMC9499634.
AÑO: 2022; IF: 5.6
Autores:
Mastrogiovanni M, Martinez-Navarro FJ, Bowman TV, Cayuela ML. Inflammation in Development and Aging: Insights from the Zebrafish Model. Int J Mol Sci. 2024 Feb 10;25(4):2145. doi: 10.3390/ijms25042145. PubMed PMID: 38396822; PubMed Central PMCID: PMC10889087.
AÑO: 2024; IF: 5.6
Autores:
Oliver-Caldes A, Espanol-Rego M, Zabaleta A, Gonzalez-Calle V, Navarro-Velazquez S, Inoges S, Lopez-Diaz de Cerio A, Cabanas V, Lopez-Munoz N, Rodriguez-Otero P, Reguera-Ortega JL, Moreno DF, Martinez-Cibrian N, Lopez-Corral L, Perez-Amill L, Martin-Antonio B, Rosinol L, Cid J, Tovar N, Saez-Penataro J, Lopez-Parra M, Olesti E, Guillen E, Varea S, Rodriguez-Lobato LG, Battram AM, Gonzalez-Perez MS, Sanchez-Salinas A, Gonzalez-Navarro A, Ortiz-Maldonado V, Delgado J, Prosper F, Juan M, Martinez-Lopez J, Moraleda JM, Mateos MV, Urbano-Ispizua A, Paiva B, Pascal M, Fernandez de Larrea C. Biomarkers of efficacy and safety of the academic BCMA-CART ARI0002h for the treatment of refractory multiple myeloma. Clin Cancer Res. 2024 Mar 11. doi: 10.1158/1078-0432.CCR-23-3759. Online ahead of print. PubMed PMID: 38466644.
AÑO: 2024; IF: 11.5

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R